XML 40 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019   69,052,873      
Beginning Balance at Dec. 31, 2019 $ 194,743 $ 7 $ 414,414 $ 142 $ (219,820)
Issuance of common stock upon follow-on public offering, net of issuance costs of $1,148 (in shares)   9,602,500      
Issuance of common stock upon follow-on public offering, net of issuance costs 224,511 $ 1 224,510    
Exercise of stock options (in shares)   655,772      
Exercise of stock options 6,331   6,331    
Purchase of common stock under employee stock purchase plan (in shares)   86,870      
Purchase of common stock under employee stock purchase plan 1,179   1,179    
Forfeiture of restricted common stock   (81,754)      
Stock-based compensation 30,522   30,522    
Unrealized gain (loss) on marketable securities 472     472  
Net loss (190,228)       (190,228)
Ending balance (in shares) at Dec. 31, 2020   79,316,261      
Ending Balance at Dec. 31, 2020 267,530 $ 8 676,956 614 (410,048)
Exercise of stock options (in shares)   2,395,223      
Exercise of stock options 28,530   28,530    
Vesting of restricted stock units   156,420      
Purchase of common stock under employee stock purchase plan (in shares)   136,331      
Purchase of common stock under employee stock purchase plan 1,765   1,765    
Forfeiture of restricted common stock   (18,043)      
Stock-based compensation 40,785   40,785    
Unrealized gain (loss) on marketable securities (1,557)     (1,557)  
Net loss $ (36,329)       (36,329)
Ending balance (in shares) at Dec. 31, 2021 81,986,192 81,986,192      
Ending Balance at Dec. 31, 2021 $ 300,724 $ 8 748,036 (943) (446,377)
Exercise of stock options (in shares)   298,238      
Exercise of stock options 3,059   3,059    
Vesting of restricted stock units   414,578      
Purchase of common stock under employee stock purchase plan (in shares)   196,710      
Purchase of common stock under employee stock purchase plan 1,455   1,455    
Stock-based compensation 46,146   46,146    
Unrealized gain (loss) on marketable securities (3,632)     (3,632)  
Net loss $ (133,310)       (133,310)
Ending balance (in shares) at Dec. 31, 2022 81,986,192 82,895,718      
Ending Balance at Dec. 31, 2022 $ 214,442 $ 8 $ 798,696 $ (4,575) $ (579,687)